Jan 29, 2026 / 10:30AM GMT
Presentation
Jan 29, 2026 / 10:30AM GMT
=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Julie Kim
Takeda Pharmaceutical Co Ltd - President of the US Business Unit, US Country Head & Interim Head of Global Portfolio Division
=====================
Conference Call Participants
=====================
* Shinichiro Muraoka
Morgan Stanley - Analyst
* Hidemaru Yamaguchi
Citi Infrastructure Investments LLC - Analyst
* Stephen Barker
Jefferies LLC - Analyst
* Hiroyuki Matsubara
Nomura Securities International Inc - Analyst
*
Takeda Pharmaceutical Co Ltd
(WBO:TKD)
€
29.91
+0.15 (+0.5%)
Market Cap: 47.49 Bil
Enterprise Value: 70.54 Bil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 19/100 Q3 2026 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Jan 29, 2026 / 10:30AM GMT
Release Date Price:
€28.71
(+2.94%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot